Genomic analysis identifies association of Fusobacterium with colorectal carcinomaOriginal paper
What was studied?
The study characterized the microbiota of colorectal carcinoma to assess whether specific microbial community changes are associated with the tumor microenvironment. It used a genomics-first approach, profiling tumor tissue against matched normal tissue and validating candidate organisms with independent molecular methods.
Who was studied?
The discovery set consisted of whole genome sequences from nine colorectal tumor/normal tissue pairs. Findings were then validated in 95 carcinoma/normal DNA pairs using quantitative PCR and 16S rDNA sequence analysis, with additional in situ confirmation by fluorescence in situ hybridization (FISH).
What were the most important findings?
Fusobacterium sequences were enriched in carcinomas relative to matched normal tissue, a result confirmed by quantitative PCR and 16S rDNA sequencing, whereas the Bacteroidetes and Firmicutes phyla were depleted in tumors. Fusobacteria were also directly visualized within colorectal tumors by FISH, supporting their physical presence in the tumor tissue.
What are the greatest implications of this study?
The authors conclude that colorectal cancer is associated with distinct alterations in the tumor microbiota, notably Fusobacterium enrichment. Because this is an observational, association-based analysis, causation is not established, and the authors state that the precise role of Fusobacteria in colorectal carcinoma pathogenesis requires further investigation.